Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
Tributes pour in for James Ransone, 'The Wire' actor who died at 46- 3D Printers for Specialists
- Beyond the habitable zone: Exoplanet atmospheres are the next clue to finding life on planets orbiting distant stars
- This St Nick Truly Can Advise How To Drink And Hack Your Headache
- 4 astronauts depart ISS, leaving behind just 3 crewmates to staff the orbiting lab
- US measles cases surpass 2,000, highest in 30 years: CDC
- The Main 20 Photography Instagram Records to Follow
- Ageless Tastefulness: An Outline of Valuable Gemstones and Adornments
- Canada cancels its 1st moon rover: 'It's hopefully not a lost cause'
